PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canad ...
Abstract
Authors
K.C. Young H. Sandhu A. Lee K. Lakhdari J. Maervoet C. Jones Y. Yuan M. Chaudhary J.R. Penrod N. Varol